In Vitro Fertilization: IVF Treatment at CHR
Medically reviewed by Norbert Gleicher, MD, FACOG, FACS - Written by CHR Staff - Updated on Oct 03, 2017
What is In Vitro Fertilization (IVF)?
In the IVF process, eggs are collected from the woman's ovaries and mixed with the man's sperm outside the body, usually in a glass dish in a laboratory. "In vitro" comes from Latin and literally means "in glass," a reference to the glass container where fertilization of the egg oocyte takes place. The fertilized eggs are then cultivated for a few days in the laboratory and transferred to the woman's uterus.
IVF treatment allows men and women to circumvent a variety of fertility problems, from tubal infertility and diminished ovarian reserve to problems with sperm. With a 30-plus-year history since the birth of the first "test-tube baby," in vitro fertilization has helped millions of couples build and expand their families. CHR, with a history nearly as long, is proud to have been instrumental in more than 18,000 pregnancies--a number still growing every day.
Individualization is Crucial for High IVF Success Rates
Dr. David H. Barad explains why individualized treatment is an absolute necessity to ensure the best in vitro fertilization success rates for each patient.
Who needs in vitro fertilization (IVF)?
Couples may benefit from in vitro fertilization (IVF) treatment if the any one of the following factors are present:
IVF Success at CHR
CHR was one of the first IVF centers in the United States and has long been recognized as one of the best IVF centers in the world. Since 1981, more than 18,000 pregnancies have been achieved at our center, using IVF and other advanced assisted reproductive technologies (ART). Some of these patients’ IVF success stories can be viewed here.
CHR experts work closely with women and couples undergoing the many different types of IVF cycle protocols with a wide array of different clinical circumstances. We are renowned for our specialized knowledge in helping patients struggling with difficult cases of infertility, often involving medical conditions that may require special considerations in planning and management of fertility treatments and those who have experienced failed IVF before. CHR's expertise in IVF success lies in our willingness and ability to individualize our approach to best suit each one of our patients.
Norbert Gleicher, MD, FACOG, FACS
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.